The bull market turned six-years-old this week, which is pretty amazing. It’s been quite a ride. In that time, the Dow Jones Industrial Average has charged ahead more than 150%, the S&P 500 180% and Nasdaq 250%. One group that has been at the forefront of this bull market is biotech stocks.Source: FlickrIn fact, the past five years have been […]
Source: Flickr user Simon & His Camera .Love is in the air, and that makes it the perfect time to confess my affection for three large-cap biotech stocks that market a slate of highly profitable, market-share leading therapies. Read on to learn more about why I have fallen for each of them.No. 1: Celgene CorporationWhile other companies hem and haw […]
Source: Flickr user Simon & His Camera .Love is in the air. At least it is for three of our top Motley Fool healthcare contributors. Each has a crush on a different biotech stock darling, and they all find their pick attractive for different reasons. Read on to learn which biotech companies have caught the fancy of these three contributors, […]
Biotech stocks are among the market’s riskiest, but investors willing to accept the potential for pipeline failure might consider owning these five small-cap biotech stocks in 2015. All five have intriguing therapies in late-stage clinical trials, and three have high-profile big-cap partners.Source: Flickr user Carlos Gracia1. Proven performerInsys Therapeutics is already rewarding shareholders with rapid sales growth and profitability, but […]
Source: Flickr user Chris PotterBiotechnology stocks were among the market’s top performers in 2014, but biotech stocks were also among the market’s riskiest plays. For risk tolerant investors, biotech’s pop-and-drop nature may be enticing, but should investors focus on big or small cap biotech stocks? We asked some of our top Motley Fool analysts for their opinion. Read on to […]
Source: MercK & Co.,Just when it looked as though the stock market couldn’t possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad bit higher than the stock markets’ historic annual return.But if you think that’s a solid return, […]
Source: ;Flickr user VastateparksstaffWhen to sell a winning stock is one of the toughest questions for investors to answer. Selling a stock that is reaching for new highs might be the right decision sometimes, but other times it might mean getting out of a long-haul opportunity too early. With that in mind, we asked three Motley Fool analysts to tell […]
Myles Udland
Nov. 17, 2014, 5:10 PM
3,509
snoboard1010 / FlickrThings have been slow in the markets. From late summer into early fall, volatility increased, culminating in October’s sharp sell off and bounce back.But since bouncing off the October 15 lows and returning to all-time highs, the S&P 500 has completely gone to sleep.And the last five closes on the S&P 500 have been […]
The S&P 500 Index, which most financial professionals use to track the performance of the overall U.S. stock market, has now officially tripled in value — along with breaking through the 2,000 level for the first time, ever.In a recent post, we looked at how often investors should expect 5% corrections, based on market history. This time, however, we’ll examine previous […]
Sam Ro
Jul. 18, 2014, 9:55 AM
1,150
Flickr / Ray Dumas
The University of Michigan’s preliminary read on consumer sentiment in July was a bit disappointing.
The headline index slipped to 81.3 from 82.5 in June.Economists estimated the headline index would climb to 83.0.The economic conditions sub-index climbed to 97.1 from 96.6.However, the outlook sub-index fell to 71.1 from 73.5.”The rise in gasoline prices […]
